<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PyngMedical.com &#187; News Releases</title>
	<atom:link href="http://www.pyng.com/category/news-releases/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.pyng.com</link>
	<description>Just another WordPress weblog</description>
	<lastBuildDate>Tue, 31 Jan 2012 21:08:18 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.1</generator>
		<item>
		<title>Pyng Medical Corp. Reports Fiscal 2011 Financial Results</title>
		<link>http://www.pyng.com/news/pyng-medical-corp-reports-fiscal-2011-financial-results/?pi=194</link>
		<comments>http://www.pyng.com/news/pyng-medical-corp-reports-fiscal-2011-financial-results/?pi=194#comments</comments>
		<pubDate>Wed, 11 Jan 2012 18:23:10 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[News Releases]]></category>

		<guid isPermaLink="false">http://www.pyng.com/?p=3372&amp;pi=194</guid>
		<description><![CDATA[Vancouver, B.C. Pyng Medical Corp. (PYT: TSX .V) today announced its financial and operating results for the year ended September 30, 2011. All amounts are in Canadian dollars unless stated otherwise. The Company reported total sales of $6,050,421 for fiscal 2011, down 15% from $7,088,837 reported for fiscal 2010. This decline in revenue was primarily [...]]]></description>
			<content:encoded><![CDATA[<p><span style="font-size: 11px"><b>Vancouver, B.C. </b>Pyng Medical Corp. (PYT: TSX .V) today announced its financial and operating results for the year ended September 30, 2011. All amounts are in Canadian dollars unless stated otherwise.</span></p>
<p><span style="font-size: 11px">The Company reported total sales of $6,050,421 for fiscal 2011, down 15% from $7,088,837 reported for fiscal 2010. This decline in revenue was primarily attributed to the significant reduction in sales during the fourth quarter resulting from reduced demand from the U.S.A. military market. Gross margin of $3,855,021 for the year ended September 30, 2011 decreased to 68% of the sales from 72% one year ago, primarily due to the lower sales. In addition, the continuous appreciation of the Canadian dollar against U.S dollar is another major contributor for the lower margin this year. The total operating expenses decreased 8% to $4,070,205 from $4,442,124 of last year as a result of lower expenses incurred on salaries and benefits, professional fees and travel expenses.</span></p>
<p><span style="font-size: 11px">The Company also reported a net loss of $194,184 this year, or loss of $0.01 per share, compared to a net income of $283,415 or earning of $0.02 per share for fiscal 2010. Earnings before interest, depreciation, amortization and taxes (&ldquo;EBITDA&rdquo;) from continuing operations decreased to $530,284, 9% of the sales compared with the EBITDA of $1,041,438, or 15% of the sales for fiscal 2010.</span></p>
<p><span style="font-size: 11px">For the fourth quarter ended September 30, 2011, the Company recorded sales of $995,611, a decrease of $1,638,184 or 62% as compared with $2,633,795 for the comparative quarter of fiscal year 2010. The operating expenses increased by 9% to $1,160,853. The net loss rose to $635,320 which reversed out the net income earned in the comparative quarter one year ago due to lower sales from the U.S.A. military in 2011.</span></p>
<p><span style="font-size: 11px">As at September 30, 2011, the Company had a cash balance of $195,414 and working capital of $113,710, representing a decrease of $87,579 and $647,545 respectively, compared to the year ended September 30, 2010. The significant decline in working capital was caused by the decrease in sales combined with FASTx re-launch costs (estimated at US$2,000,000).</span></p>
<p><span style="font-size: 11px">The Company is currently pursuing additional debt and/or equity financing to fund its working capital needs. Management hopes to secure the necessary financing through the combination of new credit facilities and issuance of new equity or convertible debt instruments. There can be no assurance that these initiatives will be successful. </span></p>
<p><span style="font-size: 11px">The Company also announced that one of the Audit Committee members Michael Jacobs has resigned from the Audit Committee leaving three remaining members, the majority of which the Company believes to be independent, and thus the resignation will not impact the ability of the Committee to function as required by TSXV Policies. </span></p>
<div><span style="font-size: 11px"><span style="font-size: 11px">Full audited financial results for fiscal year ended September 30, 2011 are available on SEDAR at </span><span style="font-size: 11px"><a href="www.sedar.com"><u><font color="#0000ff"><font color="#0000ff">www.sedar.com</font></font></u></a>.</span></span></div>
<div><span style="font-size: 11px">&nbsp;</span></div>
<div><span style="font-size: 11px"><span style="font-size: 11px"><b>About Pyng Medical Corp.</b></span></span></div>
<div><span style="font-size: 11px"><span style="font-size: 11px">Pyng Medical Corp. commercializes award-winning trauma and resuscitation products for front-line </span><span style="font-size: 11px">critical care personnel. Pyng&rsquo;s expanded product portfolio includes a variety of innovative, lifesaving </span><span style="font-size: 11px">tools. With growing markets in North America, Europe and Asia, Pyng offers user-preferred medical </span><span style="font-size: 11px">devices for use by hospital staff, emergency medical services and military forces worldwide.</span></span></div>
<div><span style="font-size: 11px"><span style="font-size: 11px">&nbsp;</span></span></div>
<div><span style="font-size: 11px"><span style="font-size: 11px"><b>For More Information</b></span></span></div>
<div><span style="font-size: 11px"><span style="font-size: 11px">George Dorin</span></span></div>
<div><span style="font-size: 11px"><span style="font-size: 11px">Chief Financial Officer</span></span></div>
<div><span style="font-size: 11px"><span style="font-size: 11px">Pyng Medical Corp.</span></span></div>
<div><span style="font-size: 11px"><span style="font-size: 11px">(604) 303-7964 ext. 219</span></span></div>
<div><span style="font-size: 11px"><span style="font-size: 11px"><a href="www.pyng.com"><u><font color="#0000ff"><font color="#0000ff">www.pyng.com</font></font></u></a></span></span></div>
<div><span style="font-size: 11px">&nbsp;</span></div>
<div><span style="font-size: 11px"><span style="font-size: 9px"><span style="font-family: arial, helvetica, sans-serif"><i>Safe Harbour Statement; Forward-Looking Statements: This release may contain forward-looking statements based </i></span><span style="font-family: arial, helvetica, sans-serif"><i>on management&#39;s expectations, estimates and projections. All statements that address expectations or projections </i></span><span style="font-family: arial, helvetica, sans-serif"><i>about the future, including statements about the Company&#39;s strategy for growth, product development, market </i></span><span style="font-family: arial, helvetica, sans-serif"><i>position, expected expenditures and financial results are forward-looking statements. Some of the forward-looking </i></span><span style="font-family: arial, helvetica, sans-serif"><i>statements may be identified by words like &quot;expects&quot;, &quot;anticipates&quot;, &quot;plans&quot;, &quot;intends&quot;, &quot;projects&quot;, &quot;indicates&quot;, and </i></span><span style="font-family: arial, helvetica, sans-serif"><i>similar expressions. These statements are not guarantees of future performance and involve a number of risks, </i></span><span style="font-family: arial, helvetica, sans-serif"><i>uncertainties and assumptions. Many factors, including those discussed more fully elsewhere in this release and in </i></span><span style="font-family: arial, helvetica, sans-serif"><i>documents which may be filed with the British Columbia Securities Commission, the Alberta Securities Commission, </i></span><span style="font-family: arial, helvetica, sans-serif"><i>the Ontario Securities Commission, the TSX Venture Exchange, as well as other USA Commissions, could cause </i></span><span style="font-family: arial, helvetica, sans-serif"><i>results to differ materially from those stated. These factors include, but are not limited to changes in the laws, </i></span><span style="font-family: arial, helvetica, sans-serif"><i>regulations, policies and economic conditions, including inflation, interest and foreign currency exchange rates, of </i></span><span style="font-family: arial, helvetica, sans-serif"><i>countries in which the Company does business; competitive pressures; successful integration of structural changes,</i></span><span style="font-family: arial, helvetica, sans-serif"><i>including restructuring plans, acquisitions, divestitures and alliances; cost of raw material, research and </i></span><span style="font-family: arial, helvetica, sans-serif"><i>development of new </i>products, including regulatory <i>approval and market acceptance; and seasonality of sales in </i></span><span style="font-family: arial, helvetica, sans-serif"><i>some products.</i></span></span></span></div>
<div><span style="font-size: 11px">&nbsp;</span></div>
<div><span style="font-size: 11px"><span style="font-size: 9px"><span style="font-family: arial, helvetica, sans-serif"><i>Neither the TSX Venture Exchange nor its Regulatory Service Provider (as that term is defined in the policies of the </i></span></span><span style="font-size: 9px"><span style="font-family: arial, helvetica, sans-serif"><i>TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.</i></span></span></span></div>
]]></content:encoded>
			<wfw:commentRss>http://www.pyng.com/news/pyng-medical-corp-reports-fiscal-2011-financial-results/?pi=194/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Spanish Army Chooses the Pyng Medical FAST1® Intraosseous Infusion System</title>
		<link>http://www.pyng.com/in-focus/spanish-army-chooses-the-pyng-medical-fast1%c2%ae-intraosseous-infusion-system/?pi=194</link>
		<comments>http://www.pyng.com/in-focus/spanish-army-chooses-the-pyng-medical-fast1%c2%ae-intraosseous-infusion-system/?pi=194#comments</comments>
		<pubDate>Tue, 10 Jan 2012 20:13:10 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[In Focus]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[News Releases]]></category>

		<guid isPermaLink="false">http://www.pyng.com/?p=3364&amp;pi=194</guid>
		<description><![CDATA[Vancouver, B.C. Pyng Medical Corp. (the &#34;Company&#34;) (PYT: TSX-V) announced today that the FAST1&#174; has been chosen by the Spanish Army through Pyng&#8217;s exclusive dealer in Spain, International Emergency Services (IES), as the standard of care for their army combat medics to carry in their medical bags. Currently used by most NATO forces including the [...]]]></description>
			<content:encoded><![CDATA[<p><span style="font-size: 11px"><b>Vancouver, B.C. </b>Pyng Medical Corp. (the &quot;Company&quot;) (PYT: TSX-V) announced today that the <em><strong>FAST1</strong></em>&reg; has been chosen by the Spanish Army through Pyng&rsquo;s exclusive dealer in Spain, International Emergency Services (IES)<span id="more-3364"></span>, as the standard of care for their army combat medics to carry in their medical bags. Currently used by most NATO forces including the United States, United Kingdom, Australia, Germany and Norway, the Spanish Army is the latest force to select the&nbsp;<strong><em>FAST1</em></strong>&reg; Intraosseous Infusion System for their vascular access needs.</span></p>
<p><span style="font-size: 11px">Responsible for land-based military operations, the Spanish Army (Ej&eacute;rcito de Tierra &#8211; &quot;Ground Army&quot;) is the terrestrial army of the Spanish Armed Forces. After much consideration and research, the Spanish Army decided that the sternal route for intraosseous infusion was the best way to administer emergency fluids and medications in battlefield situations.</span></p>
<p><span style="font-size: 11px">&ldquo;In the past, the Spanish Army has used the EZ-IO&reg; and BIG&reg; (Bone Injection Gun) systems for their intraosseous needs. However, they found that soldiers would have injuries to their extremities, exactly where these devices require deployment. They realized that the sternum was a better access point as it is one of the most protected parts on a soldier&rsquo;s body,&rdquo; commented Jesus Orbe, Director of Sales and Marketing at IES Spain.</span></p>
<p><span style="font-size: 11px">&ldquo;The&nbsp;<strong><em>FAST1</em></strong>&reg; really is a product like no other on the market. Its design and ease of use takes the guesswork out of the intraosseous infusion process. From the target patch to the automated depth control, the medic just has to find the sternal notch and deploy the device. It is easy to learn and deploy, even in low light conditions&rdquo;, added Mr. Orbe. &ldquo;These benefits in particular are the very reasons why the <strong><em>FAST1</em></strong>&reg; is the device of choice for the Spanish Army&rsquo;s intraosseous needs.&rdquo;</span></p>
<p><span style="font-size: 11px">The first order of&nbsp;<strong><em>FAST1</em></strong>&reg; for the Spanish Army will be used for a contingent of soldiers that are being deployed to Lebanon in the coming weeks. &ldquo;We are honored to offer a product such as the&nbsp;<strong><em>FAST1</em></strong>&reg; with its high degree of success, ease-of-use and dependability,&rdquo; noted Mr. Orbe.</span></p>
<p><span style="font-size: 11px"><span style="font-size: 11px"><span style="font-size: 11px"><b>About International Emergency Services</b><br />
	International Emergency Services is a Spanish distributor of emergency medical supplies. For more information, please visit their website at www.ies-spain.com.</span></span></span></p>
<p><span style="font-size: 11px"><span style="font-size: 11px"><span style="font-size: 11px"><b>About Pyng Medical Corp.</b><br />
	Pyng Medical Corp. commercializes award-winning trauma and resuscitation products for front-line critical care personnel. Pyng&rsquo;s expanded product portfolio includes a variety of innovative, lifesaving tools. With growing markets in North America, Europe and Asia, Pyng offers user-preferred medical devices for use by hospital staff, emergency medical services and military forces worldwide.</span></span></span></p>
<p><span style="font-size: 11px"><span style="font-size: 11px"><b><span style="font-size: 11px"><span _fck_bookmark="1" style="display: none">&nbsp;</span><span style="font-size: 11px">&nbsp;</span></span></b></span></span></p>
<div><span style="font-size: 11px"><span style="font-size: 11px"><b><span style="font-size: 11px"><span style="font-size: 11px"><b>For More Information</b></span></span></b></span></span></div>
<div><span style="font-size: 11px"><span style="font-size: 11px"><span style="font-size: 11px"><span style="font-size: 11px">Claude Neunlist</span></span></span></span></div>
<div><span style="font-size: 11px"><span style="font-size: 11px"><span style="font-size: 11px"><span style="font-size: 11px">Director of International Sales</span></span></span></span></div>
<div><span style="font-size: 11px"><span style="font-size: 11px"><span style="font-size: 11px"><span style="font-size: 11px">Pyng Medical Corp.</span></span></span></span></div>
<div><span style="font-size: 11px"><span style="font-size: 11px"><span style="font-size: 11px"><span style="font-size: 11px">+1-514-671-0225</span></span></span></span></div>
<div><span style="font-size: 11px"><span style="font-size: 11px"><span style="font-size: 11px"><span style="font-size: 11px"><a href="mailto:cneunlist@pyng.com">cneunlist@pyng.com</a></span></span></span></span></div>
<div><span style="font-size: 11px"><span style="font-size: 11px"><span style="font-size: 11px"><span style="font-size: 11px"><a href="http://www.pyng.com"><u><font color="#0000ff"><font color="#0000ff">www.pyng.com</font></font></u></a></span></span></span></span></div>
<div><span style="font-size: 11px"><span style="font-size: 11px">&nbsp;</span></span></div>
<div><span style="font-size: 11px"><span style="font-size: 11px"><span style="font-size: 11px"><span style="font-size: 11px">Nadine Siqueland</span></span></span></span></div>
<div><span style="font-size: 11px"><span style="font-size: 11px"><span style="font-size: 11px"><span style="font-size: 11px">VP Global Sales and Marketing</span></span></span></span></div>
<div><span style="font-size: 11px"><span style="font-size: 11px"><span style="font-size: 11px"><span style="font-size: 11px">Pyng Medical Corp.</span></span></span></span></div>
<div><span style="font-size: 11px"><span style="font-size: 11px"><span style="font-size: 11px"><span style="font-size: 11px">+1-206-226-3082</span></span></span></span></div>
<div><span style="font-size: 11px"><span style="font-size: 11px"><span style="font-size: 11px"><span style="font-size: 11px"><a href="mailto:nsiqueland@pyng.com">nsiqueland@pyng.com</a></span></span></span></span></div>
<div><span style="font-size: 11px"><span style="font-size: 11px"><span style="font-size: 11px"><span style="font-size: 11px"><a href="http://www.pyng.com"><u><font color="#0000ff"><font color="#0000ff">www.pyng.com</font></font></u></a></span></span></span></span></div>
<div><span style="font-size: 11px"><span style="font-size: 11px"><b><span style="font-size: 11px">&nbsp;</span></b></span></span></div>
<div><span style="font-size: 11px"><span style="font-size: 11px"><b><span style="font-size: 11px">&nbsp;</span></b></span></span></div>
<div><span style="font-size: 11px"><span style="font-size: 11px"><span style="font-size: 11px"><span style="font-size: 11px"><span style="font-size: 9px"><span style="font-family: arial, helvetica, sans-serif"><i>Safe Harbour Statement; Forward-Looking Statements: This release may contain forward-looking statements based </i></span><span style="font-family: arial, helvetica, sans-serif"><i>on management&#39;s expectations, estimates and projections. All statements that address expectations or projections </i></span><span style="font-family: arial, helvetica, sans-serif"><i>about the future, including statements about the Company&#39;s strategy for growth, product development, market </i></span><span style="font-family: arial, helvetica, sans-serif"><i>position, expected expenditures and financial results are forward-looking statements. Some of the forward-looking </i></span><span style="font-family: arial, helvetica, sans-serif"><i>statements may be identified by words like &quot;expects&quot;, &quot;anticipates&quot;, &quot;plans&quot;, &quot;intends&quot;, &quot;projects&quot;, &quot;indicates&quot;, and </i></span><span style="font-family: arial, helvetica, sans-serif"><i>similar expressions. These statements are not guarantees of future performance and involve a number of risks, </i></span><span style="font-family: arial, helvetica, sans-serif"><i>uncertainties and assumptions. Many factors, including those discussed more fully elsewhere in this release and in </i></span><span style="font-family: arial, helvetica, sans-serif"><i>documents which may be filed with the British Columbia Securities Commission, the Alberta Securities Commission, </i></span><span style="font-family: arial, helvetica, sans-serif"><i>the Ontario Securities Commission, the TSX Venture Exchange, as well as other USA Commissions, could cause </i></span><span style="font-family: arial, helvetica, sans-serif"><i>results to differ materially from those stated. These factors include, but are not limited to changes in the laws, </i></span><span style="font-family: arial, helvetica, sans-serif"><i>regulations, policies and economic conditions, including inflation, interest and foreign currency exchange rates, of </i></span><span style="font-family: arial, helvetica, sans-serif"><i>countries in which the Company does business; competitive pressures; successful integration of structural changes,</i></span><span style="font-family: arial, helvetica, sans-serif"><i>including restructuring plans, acquisitions, divestitures and alliances; cost of raw material, research and </i></span><span style="font-family: arial, helvetica, sans-serif"><i>development of new </i>products, including regulatory <i>approval and market acceptance; and seasonality of sales in </i></span><span style="font-family: arial, helvetica, sans-serif"><i>some products.</i></span></span></span></span></span></span></div>
<div><span style="font-size: 11px"><span style="font-size: 11px"><span style="font-size: 11px"><span style="font-size: 11px">&nbsp;</span></span></span></span></div>
<div><span style="font-size: 11px"><span style="font-size: 11px"><span style="font-size: 11px"><span style="font-size: 11px"><span style="font-size: 9px"><span style="font-family: arial, helvetica, sans-serif"><i>Neither the TSX Venture Exchange nor its Regulatory Service Provider (as that term is defined in the policies of the </i></span></span><span style="font-size: 9px"><span style="font-family: arial, helvetica, sans-serif"><i>TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.</i></span></span></span></span></span></span></div>
]]></content:encoded>
			<wfw:commentRss>http://www.pyng.com/in-focus/spanish-army-chooses-the-pyng-medical-fast1%c2%ae-intraosseous-infusion-system/?pi=194/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>St John Ambulance of Western Australia Chooses the Pyng Medical T-POD&#174;</title>
		<link>http://www.pyng.com/in-focus/3195/?pi=194</link>
		<comments>http://www.pyng.com/in-focus/3195/?pi=194#comments</comments>
		<pubDate>Mon, 14 Nov 2011 17:45:22 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[In Focus]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[News Releases]]></category>

		<guid isPermaLink="false">http://www.pyng.com/?p=3195&amp;pi=194</guid>
		<description><![CDATA[Vancouver, B.C. Pyng Medical Corp. (the &#34;Company&#34;) (PYT: TSX-V) announced today that the T-POD&#174; has been chosen by St John Ambulance Western Australia, through Pyng&#8217;s exclusive dealer in Australia, Midmed, as their standard of care for their fleet of ambulances and first aid responders. &#8220;St John Ambulance is thrilled to have the T-POD&#174; on board [...]]]></description>
			<content:encoded><![CDATA[<p><span style="font-size: 11px"><b>Vancouver, B.C. </b>Pyng Medical Corp. (the &quot;Company&quot;) (PYT: TSX-V) announced today that the <strong><em>T-POD&reg;</em></strong> has been chosen by St John Ambulance Western Australia<span id="more-3195"></span>, through Pyng&rsquo;s exclusive dealer in Australia, Midmed, as their standard of care for their fleet of ambulances and first aid responders. </span></p>
<p><span style="font-size: 11px">&ldquo;St John Ambulance is thrilled to have the <strong><em>T-POD&reg;</em></strong> on board their ambulances as they have been very pleased with the results the <strong><em>T-POD&reg;</em></strong> has produced being used on their helicopter fleet,&rdquo; commented Steve Muller, Sales Director for Midmed. </span></p>
<p><span style="font-size: 11px">The Emergency Rescue Helicopter Service division of St John Ambulance Western Australia has used the <strong><em>T-POD&reg;</em></strong> on their fleet for two years with very positive and well-received results. St John Ambulance Western Australia has now decided to rollout the <strong><em>T-POD&reg;</em></strong> product across their complete service, including their fleet of over 90 ambulances in the Perth Metropolitan area and their ambulance fleet in Country Western Australia. </span></p>
<p><span style="font-size: 11px">The <strong><em>T-POD&reg;</em></strong> will be used by the St John Ambulance first responders, advanced responders, doctors, nurses and paramedics who offer first aid services at public events and emergencies.</span></p>
<p><span style="font-size: 11px">&ldquo;The <strong><em>T-POD&reg;</em></strong> is a superb product that stands out from its competition. When compared to other pelvic stabilization devices that are on the market, the benefits and features of the <strong><em>T-POD&reg;</em></strong> make it a clear winner,&rdquo; added Mr. Muller. &ldquo;This is especially true for St John Ambulance, as they were looking for a product that is lightweight and with a size that fits most patients, eliminating the need to stock multiple sizes of a single product.</span></p>
<p><span style="font-size: 11px">Currently, the <strong><em>T-POD&reg;</em></strong> is part of the standard equipment on board all aircrafts of the Royal Flying Doctor Service of Australia. The Royal Flying Doctor Service of Australia provides 24 hour emergency services and everyday essential healthcare to the people living, working and travelling in the remote and rural areas of Australia. </span></p>
<p><span style="font-size: 11px"><b>About St John Ambulance</b><br />
	St John Ambulance Australia is a self-funding charitable organization active in all States and Territories for over 125 years, dedicated to helping people in sickness, distress, suffering or danger. In addition to providing ambulance service in Western Australia and the Northern Territory through their 3500 paid and volunteer ambulance officers, St John Ambulance also provides first aid training, first aid kits, first aid services at community and public events and assistance during national disaster relief, and a range of community care services for the aged, the infirm, the immobile and the lonely.</span></p>
<p><span style="font-size: 11px">St John Ambulance has been serving the Western Australian community for over 100 years, providing ambulance and paramedic services, first aid training, volunteer first aid services at public events, and community services for the lonely, fragile aged and disabled through their 600 career ambulance officers and 2500 volunteer ambulance officers. </span></p>
<p><span style="font-size: 11px"><b>About Midmed</b><br />
	Midmed is an Australian family owned medical equipment supplier that has been supplying medical equipment to public and private hospitals, Pre Hospital/Ambulance, Specialists, GP&rsquo;s, medical centres, allied health professionals and other businesses for over 17 years. They offer an extensive range of durable and cost-effective medical equipment, medical supplies, hospital supplies and surgical supplies.</span></p>
<p><span style="font-size: 11px"><b>About Pyng Medical Corp.</b><br />
	Pyng Medical Corp. commercializes award-winning trauma and resuscitation products for front-line critical care personnel. Pyng&rsquo;s expanded product portfolio includes a variety of innovative, lifesaving tools. With growing markets in North America, Europe and Asia, Pyng offers user-preferred medical devices for use by hospital staff, emergency medical services and military forces worldwide.</span></p>
<p><b><span style="font-size: 11px"><span _fck_bookmark="1" style="display: none">&nbsp;</span><span style="font-size: 11px">&nbsp;</span></span></b></p>
<div><b><span style="font-size: 11px"><span style="font-size: 11px"><b>For More Information</b></span></span></b></div>
<div><span style="font-size: 11px"><span style="font-size: 11px">Claude Neunlist</span></span></div>
<div><span style="font-size: 11px"><span style="font-size: 11px">Director of International Sales</span></span></div>
<div><span style="font-size: 11px"><span style="font-size: 11px">Pyng Medical Corp.</span></span></div>
<div><span style="font-size: 11px"><span style="font-size: 11px">+1-514-671-0225</span></span></div>
<div><span style="font-size: 11px"><span style="font-size: 11px"><a href="mailto:cneunlist@pyng.com">cneunlist@pyng.com</a></span></span></div>
<div><span style="font-size: 11px"><span style="font-size: 11px"><a href="http://www.pyng.com"><u><font color="#0000ff"><font color="#0000ff">www.pyng.com</font></font></u></a></span></span></div>
<div>&nbsp;</div>
<div><span style="font-size: 11px"><span style="font-size: 11px">Nadine Siqueland</span></span></div>
<div><span style="font-size: 11px"><span style="font-size: 11px">VP Global Sales and Marketing</span></span></div>
<div><span style="font-size: 11px"><span style="font-size: 11px">Pyng Medical Corp.</span></span></div>
<div><span style="font-size: 11px"><span style="font-size: 11px">+1-206-226-3082</span></span></div>
<div><span style="font-size: 11px"><span style="font-size: 11px"><a href="mailto:nsiqueland@pyng.com">nsiqueland@pyng.com</a></span></span></div>
<div><span style="font-size: 11px"><span style="font-size: 11px"><a href="http://www.pyng.com"><u><font color="#0000ff"><font color="#0000ff">www.pyng.com</font></font></u></a></span></span></div>
<div><b><span style="font-size: 11px">&nbsp;</span></b></div>
<div><b><span style="font-size: 11px">&nbsp;</span></b></div>
<div><span style="font-size: 11px"><span style="font-size: 11px"><span style="font-size: 9px"><span style="font-family: arial, helvetica, sans-serif"><i>Safe Harbour Statement; Forward-Looking Statements: This release may contain forward-looking statements based </i></span><span style="font-family: arial, helvetica, sans-serif"><i>on management&#39;s expectations, estimates and projections. All statements that address expectations or projections </i></span><span style="font-family: arial, helvetica, sans-serif"><i>about the future, including statements about the Company&#39;s strategy for growth, product development, market </i></span><span style="font-family: arial, helvetica, sans-serif"><i>position, expected expenditures and financial results are forward-looking statements. Some of the forward-looking </i></span><span style="font-family: arial, helvetica, sans-serif"><i>statements may be identified by words like &quot;expects&quot;, &quot;anticipates&quot;, &quot;plans&quot;, &quot;intends&quot;, &quot;projects&quot;, &quot;indicates&quot;, and </i></span><span style="font-family: arial, helvetica, sans-serif"><i>similar expressions. These statements are not guarantees of future performance and involve a number of risks, </i></span><span style="font-family: arial, helvetica, sans-serif"><i>uncertainties and assumptions. Many factors, including those discussed more fully elsewhere in this release and in </i></span><span style="font-family: arial, helvetica, sans-serif"><i>documents which may be filed with the British Columbia Securities Commission, the Alberta Securities Commission, </i></span><span style="font-family: arial, helvetica, sans-serif"><i>the Ontario Securities Commission, the TSX Venture Exchange, as well as other USA Commissions, could cause </i></span><span style="font-family: arial, helvetica, sans-serif"><i>results to differ materially from those stated. These factors include, but are not limited to changes in the laws, </i></span><span style="font-family: arial, helvetica, sans-serif"><i>regulations, policies and economic conditions, including inflation, interest and foreign currency exchange rates, of </i></span><span style="font-family: arial, helvetica, sans-serif"><i>countries in which the Company does business; competitive pressures; successful integration of structural changes,</i></span><span style="font-family: arial, helvetica, sans-serif"><i>including restructuring plans, acquisitions, divestitures and alliances; cost of raw material, research and </i></span><span style="font-family: arial, helvetica, sans-serif"><i>development of new </i>products, including regulatory <i>approval and market acceptance; and seasonality of sales in </i></span><span style="font-family: arial, helvetica, sans-serif"><i>some products.</i></span></span></span></span></div>
<div><span style="font-size: 11px"><span style="font-size: 11px">&nbsp;</span></span></div>
<div><span style="font-size: 11px"><span style="font-size: 11px"><span style="font-size: 9px"><span style="font-family: arial, helvetica, sans-serif"><i>Neither the TSX Venture Exchange nor its Regulatory Service Provider (as that term is defined in the policies of the </i></span></span><span style="font-size: 9px"><span style="font-family: arial, helvetica, sans-serif"><i>TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.</i></span></span></span></span></div>
]]></content:encoded>
			<wfw:commentRss>http://www.pyng.com/in-focus/3195/?pi=194/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pyng Medical T-POD&#174; Chosen for the Romanian Ambulance and Emergency Service</title>
		<link>http://www.pyng.com/in-focus/pyng-medical-t-pod-chosen-for-the-romanian-ambulance-and-emergency-service/?pi=194</link>
		<comments>http://www.pyng.com/in-focus/pyng-medical-t-pod-chosen-for-the-romanian-ambulance-and-emergency-service/?pi=194#comments</comments>
		<pubDate>Thu, 25 Aug 2011 20:10:16 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[In Focus]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[News Releases]]></category>

		<guid isPermaLink="false">http://www.pyng.com/?p=3097&amp;pi=194</guid>
		<description><![CDATA[Vancouver, B.C. Pyng Medical Corp. (the &#34;Company&#34;) (PYT: TSX-V) announced today that the T-POD&#174; has been chosen by the Romanian Ambulance Services.The supply contract will be for a period of four years through Pyng&#8217;s exclusive dealer in Romania, Deltamed Ltd. Their decision was made after a careful review of pelvic stabilization devices available in the [...]]]></description>
			<content:encoded><![CDATA[<p><span style="font-size: 11px"><b>Vancouver, B.C. </b>Pyng Medical Corp. (the &quot;Company&quot;) (PYT: TSX-V) announced today that the <strong><em>T-POD&reg;</em></strong> has been chosen by the Romanian Ambulance Services.<span id="more-3097"></span>The supply contract will be for a period of four years through Pyng&rsquo;s exclusive dealer in Romania, Deltamed Ltd. </span></p>
<p><span style="font-size: 11px">Their decision was made after a careful review of pelvic stabilization devices available in the market and after consulting with emergency specialists. </span></p>
<p><span style="font-size: 11px">Both Romanian Emergency Services, the Romanian Ambulance and SMURD, the Romanian Mobile Emergency Service for Resuscitation and Extrication, will be using the <strong><em>T-POD&reg;</em></strong> as part of the standard equipment on board their ambulance fleet of about 500 vehicles. &ldquo;Our customers rely on us to make the best recommendation for which products they should use on their patients. We feel that the <strong><em>T-POD&reg;</em></strong> will not let them down,&rdquo; added Mr. Dan Gorgan, President of Deltamed.</span></p>
<p><span style="font-size: 11px">&ldquo;The <strong><em>T-POD&reg;</em></strong> presents many advantages, the biggest being its one size fits all characteristic. We also liked the uniform/symmetrical compression features and the fact that it is already the standard of care in other European countries. When choosing a product to be placed on board our ambulances, we need one that will be easy to deploy and as effective as possible. By being able to use one product for the majority of patients and by having such positive effects on the blood transfusion requirement, hospital stay, and morbidity, the <strong><em>T-POD&reg;</em></strong> was the only pelvic stabilization device that our customers felt comfortable with,&rdquo; added Mr. Gorgan, who was echoing the feedback from the Romanian Emergency Services.</span></p>
<p><span style="font-size: 11px"><b>About Deltamed Ltd.</b><br />
	Deltamed was founded in 1997 as a privately owned company in Cluj-Napoca, Romania. They provide complete solutions for emergency situations including safety equipment, medical supplies, resuscitation equipment, protective equipment, immobilization and transport equipment, diagnostic and therapy equipment, and emergency vehicles.</span></p>
<div><span style="font-size: 11px"><b><b>About Pyng Medical Corp.</b></b></span><span _fck_bookmark="1" style="display: none">&nbsp;</span></div>
<div><span style="font-size: 11px">Pyng Medical Corp. commercializes award-winning trauma and resuscitation products for front-line critical care personnel. Pyng&rsquo;s expanded product portfolio includes a variety of innovative, lifesaving tools. With growing markets in North America, Europe and Asia, Pyng offers user-preferred medical devices for use by hospital staff, emergency medical services and military forces worldwide.</span></div>
<p><span _fck_bookmark="1" style="display: none">&nbsp;</span><span style="font-size: 11px">&nbsp;</span></p>
<div><span style="font-size: 11px"><b>For More Information</b></span></div>
<div><span style="font-size: 11px">Claude Neunlist</span></div>
<div><span style="font-size: 11px">Director of International Sales</span></div>
<div><span style="font-size: 11px">Pyng Medical Corp.</span></div>
<div><span style="font-size: 11px">+1-514-671-0225</span></div>
<div><span style="font-size: 11px"><a href="mailto:cneunlist@pyng.com">cneunlist@pyng.com</a></span></div>
<div><span style="font-size: 11px"><a href="http://www.pyng.com"><u><font color="#0000ff"><font color="#0000ff">www.pyng.com</font></font></u></a></span></div>
<div>&nbsp;</div>
<div>&nbsp;</div>
<div><span style="font-size: 11px"><span style="font-size: 9px"><span style="font-family: arial, helvetica, sans-serif"><i>Safe Harbour Statement; Forward-Looking Statements: This release may contain forward-looking statements based </i></span><span style="font-family: arial, helvetica, sans-serif"><i>on management&#39;s expectations, estimates and projections. All statements that address expectations or projections </i></span><span style="font-family: arial, helvetica, sans-serif"><i>about the future, including statements about the Company&#39;s strategy for growth, product development, market </i></span><span style="font-family: arial, helvetica, sans-serif"><i>position, expected expenditures and financial results are forward-looking statements. Some of the forward-looking </i></span><span style="font-family: arial, helvetica, sans-serif"><i>statements may be identified by words like &quot;expects&quot;, &quot;anticipates&quot;, &quot;plans&quot;, &quot;intends&quot;, &quot;projects&quot;, &quot;indicates&quot;, and </i></span><span style="font-family: arial, helvetica, sans-serif"><i>similar expressions. These statements are not guarantees of future performance and involve a number of risks, </i></span><span style="font-family: arial, helvetica, sans-serif"><i>uncertainties and assumptions. Many factors, including those discussed more fully elsewhere in this release and in </i></span><span style="font-family: arial, helvetica, sans-serif"><i>documents which may be filed with the British Columbia Securities Commission, the Alberta Securities Commission, </i></span><span style="font-family: arial, helvetica, sans-serif"><i>the Ontario Securities Commission, the TSX Venture Exchange, as well as other USA Commissions, could cause </i></span><span style="font-family: arial, helvetica, sans-serif"><i>results to differ materially from those stated. These factors include, but are not limited to changes in the laws, </i></span><span style="font-family: arial, helvetica, sans-serif"><i>regulations, policies and economic conditions, including inflation, interest and foreign currency exchange rates, of </i></span><span style="font-family: arial, helvetica, sans-serif"><i>countries in which the Company does business; competitive pressures; successful integration of structural changes,</i></span><span style="font-family: arial, helvetica, sans-serif"><i>including restructuring plans, acquisitions, divestitures and alliances; cost of raw material, research and </i></span><span style="font-family: arial, helvetica, sans-serif"><i>development of new </i>products, including regulatory <i>approval and market acceptance; and seasonality of sales in </i></span><span style="font-family: arial, helvetica, sans-serif"><i>some products.</i></span></span></span></div>
<div><span style="font-size: 11px">&nbsp;</span></div>
<div><span style="font-size: 11px"><span style="font-size: 9px"><span style="font-family: arial, helvetica, sans-serif"><i>Neither the TSX Venture Exchange nor its Regulatory Service Provider (as that term is defined in the policies of the </i></span></span><span style="font-size: 9px"><span style="font-family: arial, helvetica, sans-serif"><i>TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.</i></span></span></span></div>
]]></content:encoded>
			<wfw:commentRss>http://www.pyng.com/in-focus/pyng-medical-t-pod-chosen-for-the-romanian-ambulance-and-emergency-service/?pi=194/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pyng Medical Corp. Reports Third Quarter Fiscal 2011 Results</title>
		<link>http://www.pyng.com/news/pyng-medical-corp-reports-third-quarter-fiscal-2011-results/?pi=194</link>
		<comments>http://www.pyng.com/news/pyng-medical-corp-reports-third-quarter-fiscal-2011-results/?pi=194#comments</comments>
		<pubDate>Wed, 24 Aug 2011 17:15:20 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[News Releases]]></category>

		<guid isPermaLink="false">http://www.pyng.com/?p=3088&amp;pi=194</guid>
		<description><![CDATA[Vancouver, B.C. Pyng Medical Corp. (PYT: TSX .V) today announced it&#8217;s financial and operating results for the three months ended June 30, 2011. All amounts are in Canadian dollars unless stated otherwise. &#160; For the third quarter 2011, the Company has realized significant sales growth resulting in total sales of $1,723,803, up 34% from the [...]]]></description>
			<content:encoded><![CDATA[<p><span id="more-3088"></span><span style="font-size: 11px"><b>Vancouver, B.C. </b>Pyng Medical Corp. (PYT: TSX .V) today announced it&rsquo;s financial and operating results for the three months ended June 30, 2011. All amounts are in Canadian dollars unless stated otherwise. </span></p>
<div>&nbsp;</div>
<div><span style="font-size: 11px">For the third quarter 2011, the Company has realized significant sales growth resulting in total sales of $1,723,803, up 34% from the third quarter 2010. This increase was mainly attributed to the sales from U.S. military and civilian orders after the budget issue of the U.S. government was resolved. Gross margin as a percentage of sales of 65% was slightly higher than the prior year at 64% as a result of the strong sales and cost savings, despite continuing appreciation of Canadian dollar against the U.S. dollar, causing an unfavorable effect on the majority of sales dominated in U.S. dollars. Total operating expenses dropped to 53% of the sales from 72% for the same quarter last year. </span></div>
<div>&nbsp;</div>
<div><span style="font-size: 11px">The Company&rsquo;s net income also rose substantially to $210,555 for this quarter, equal to $0.01 per share, compared to a net loss of $92,990 or a loss of $0.01 per share one year earlier. Earnings before interest, depreciation, amortization and taxes (&ldquo;EBITDA&rdquo;) from continuing operations were $379,344, an increase of $322,446 as compared to $56,898 reported one year ago.</span></div>
<div>&nbsp;</div>
<div><span style="font-size: 11px">For the nine months period, the total sales climbed 13% to $5,054,810 from $4,455,042 for the comparable period last year. Meanwhile, operating expenses were down 14% to $2,909,352 from $3,377,924 incurred one year ago. The strong sales and numerous initiatives on cost saving and expense reduction have collectively contributed to an increase of $757,437 in net income to $420,136 from a net loss of $337,301 reported last year. </span></div>
<div>&nbsp;</div>
<div><span style="font-size: 11px">In addition to the improving profitability, the Company continued to maintain sufficient financial liquidity to support the profit growth and product development. As of June 30, 2011, the cash balance and working capital have increased to $305,743 and $1,183,316 respectively, as compared to the amounts of $282,993 and $761,255 as at September 30, 2010. </span></div>
<div>&nbsp;</div>
<div><span style="font-size: 11px">Full audited financial results for fiscal year ended September 30, 2010 are available on SEDAR at </span><span style="font-size: 11px"><a href="www.sedar.com"><u><font color="#0000ff"><font color="#0000ff">www.sedar.com</font></font></u></a>.</span></div>
<div>&nbsp;</div>
<div><span style="font-size: 11px"><b>About Pyng Medical Corp.</b></span></div>
<div><span style="font-size: 11px">Pyng Medical Corp. commercializes award-winning trauma and resuscitation products for front-line </span><span style="font-size: 11px">critical care personnel. Pyng&rsquo;s expanded product portfolio includes a variety of innovative, lifesaving </span><span style="font-size: 11px">tools. With growing markets in North America, Europe and Asia, Pyng offers user-preferred medical </span><span style="font-size: 11px">devices for use by hospital staff, emergency medical services and military forces worldwide.</span></div>
<div><span style="font-size: 11px">&nbsp;</span></div>
<div><span style="font-size: 11px"><b>For More Information</b></span></div>
<div><span style="font-size: 11px">George Dorin</span></div>
<div><span style="font-size: 11px">Chief Financial Officer</span></div>
<div><span style="font-size: 11px">Pyng Medical Corp.</span></div>
<div><span style="font-size: 11px">(604) 303-7964 ext. 219</span></div>
<div><span style="font-size: 11px"><a href="www.pyng.com"><u><font color="#0000ff"><font color="#0000ff">www.pyng.com</font></font></u></a></span></div>
<div>&nbsp;</div>
<div><span style="font-size: 9px"><span style="font-family: arial, helvetica, sans-serif"><i>Safe Harbour Statement; Forward-Looking Statements: This release may contain forward-looking statements based </i></span><span style="font-family: arial, helvetica, sans-serif"><i>on management&#39;s expectations, estimates and projections. All statements that address expectations or projections </i></span><span style="font-family: arial, helvetica, sans-serif"><i>about the future, including statements about the Company&#39;s strategy for growth, product development, market </i></span><span style="font-family: arial, helvetica, sans-serif"><i>position, expected expenditures and financial results are forward-looking statements. Some of the forward-looking </i></span><span style="font-family: arial, helvetica, sans-serif"><i>statements may be identified by words like &quot;expects&quot;, &quot;anticipates&quot;, &quot;plans&quot;, &quot;intends&quot;, &quot;projects&quot;, &quot;indicates&quot;, and </i></span><span style="font-family: arial, helvetica, sans-serif"><i>similar expressions. These statements are not guarantees of future performance and involve a number of risks, </i></span><span style="font-family: arial, helvetica, sans-serif"><i>uncertainties and assumptions. Many factors, including those discussed more fully elsewhere in this release and in </i></span><span style="font-family: arial, helvetica, sans-serif"><i>documents which may be filed with the British Columbia Securities Commission, the Alberta Securities Commission, </i></span><span style="font-family: arial, helvetica, sans-serif"><i>the Ontario Securities Commission, the TSX Venture Exchange, as well as other USA Commissions, could cause </i></span><span style="font-family: arial, helvetica, sans-serif"><i>results to differ materially from those stated. These factors include, but are not limited to changes in the laws, </i></span><span style="font-family: arial, helvetica, sans-serif"><i>regulations, policies and economic conditions, including inflation, interest and foreign currency exchange rates, of </i></span><span style="font-family: arial, helvetica, sans-serif"><i>countries in which the Company does business; competitive pressures; successful integration of structural changes,</i></span><span style="font-family: arial, helvetica, sans-serif"><i>including restructuring plans, acquisitions, divestitures and alliances; cost of raw material, research and </i></span><span style="font-family: arial, helvetica, sans-serif"><i>development of new </i>products, including regulatory <i>approval and market acceptance; and seasonality of sales in </i></span><span style="font-family: arial, helvetica, sans-serif"><i>some products.</i></span></span></div>
<div>&nbsp;</div>
<div><span style="font-size: 9px"><span style="font-family: arial, helvetica, sans-serif"><i>Neither the TSX Venture Exchange nor its Regulatory Service Provider (as that term is defined in the policies of the </i></span></span><span style="font-size: 9px"><span style="font-family: arial, helvetica, sans-serif"><i>TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.</i></span></span></div>
]]></content:encoded>
			<wfw:commentRss>http://www.pyng.com/news/pyng-medical-corp-reports-third-quarter-fiscal-2011-results/?pi=194/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pyng Medical Announces Release of E-MAT – Emergency Medical Tourniquet – for the EMS Market</title>
		<link>http://www.pyng.com/in-focus/pyng-medical-announces-release-of-e-mat-%e2%80%93-emergency-medical-tourniquet-%e2%80%93-for-the-ems-market/?pi=194</link>
		<comments>http://www.pyng.com/in-focus/pyng-medical-announces-release-of-e-mat-%e2%80%93-emergency-medical-tourniquet-%e2%80%93-for-the-ems-market/?pi=194#comments</comments>
		<pubDate>Fri, 10 Jun 2011 13:00:26 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[In Focus]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[News Releases]]></category>

		<guid isPermaLink="false">http://www.pyng.com/?p=2719&amp;pi=194</guid>
		<description><![CDATA[Vancouver, B.C. Pyng Medical Corp. (the &#34;Company&#34;) (PYT: TSX-V) announced today the release of their tourniquet marketed for the Emergency Medical Services (EMS) Market&#8211; E-MAT&#8482;. &#8221;We are very excited to be launching this product for the EMS Market at a time when new tourniquet protocols are being introduced and implemented world-wide,&#8221; commented Nadine Siqueland Gaston, [...]]]></description>
			<content:encoded><![CDATA[<p><b>Vancouver, B.C. </b>Pyng Medical Corp. (the &quot;Company&quot;) (PYT: TSX-V) announced today the release of their tourniquet marketed for<span id="more-2719"></span> the Emergency Medical Services (EMS) Market&ndash; <strong><em>E-MAT&trade;</em></strong>.</p>
<p>&rdquo;We are very excited to be launching this product for the EMS Market at a time when new tourniquet protocols are being introduced and implemented world-wide,&rdquo; commented Nadine Siqueland Gaston, Vice President of Global Sales and Marketing for Pyng.</p>
<p>The <strong><em>E-MAT&trade;</em></strong> features a bright, EMS orange color, setting it apart from its surroundings and making it noticeable at an accident scene. &ldquo;This new high-visibility color will make it easy to see that a tourniquet has been placed on a patient,&rdquo; added Nadine. &ldquo;It is also lightweight and compact, making it an easy fit into any medical bag.&rdquo;</p>
<p>With its new color, the <strong><em>E-MAT&trade;</em></strong> contains all the same award-winning features of the original <strong><em>MAT&reg;</em></strong>. By providing fast and easy application, even to trapped limbs, complete blood flow occlusion is achieved in under 30 seconds. &ldquo;The <strong><em>E-MAT&trade;</em></strong> offers First Responders a quick and simple solution to stop severe extremity blood loss, allowing them time to asses other injuries,&rdquo; added Ms. Gaston.</p>
<div><span style="font-size: 11px"><span style="font-size: 11px"><b>About Pyng Medical Corp.</b></span></span></div>
<div><span style="font-size: 11px"><span style="font-size: 11px">Pyng Medical Corp. commercializes award-winning trauma and resuscitation products for front-line </span><span style="font-size: 11px">critical care personnel. Pyng&rsquo;s expanded product portfolio includes a variety of innovative, lifesaving </span><span style="font-size: 11px">tools. With growing markets in North America, Europe and Asia, Pyng offers user-preferred medical </span><span style="font-size: 11px">devices for use by hospital staff, emergency medical services and military forces worldwide.</span></span></div>
<div><span style="font-size: 11px"><span style="font-size: 11px">&nbsp;</span></span></div>
<div><span style="font-size: 11px"><span style="font-size: 11px"><b>For More Information</b></span></span></div>
<div><span style="font-size: 11px"><span style="font-size: 11px">Nadine Siqueland Gaston</span></span></div>
<div><span style="font-size: 11px"><span style="font-size: 11px">Pyng Medical Corp.</span></span></div>
<div><span style="font-size: 11px"><span style="font-size: 11px">206.226.3082</span></span></div>
<div><span style="font-size: 11px"><span style="font-size: 11px"><a href="www.pyng.com"><u><font color="#0000ff"><font color="#0000ff">www.pyng.com</font></font></u></a></span></span></div>
<div><span style="font-size: 11px">&nbsp;</span></div>
<div><span style="font-size: 11px"><span style="font-size: 9px"><span style="font-family: arial, helvetica, sans-serif"><i>Safe Harbour Statement; Forward-Looking Statements: This release may contain forward-looking statements based </i></span><span style="font-family: arial, helvetica, sans-serif"><i>on management&#39;s expectations, estimates and projections. All statements that address expectations or projections </i></span><span style="font-family: arial, helvetica, sans-serif"><i>about the future, including statements about the Company&#39;s strategy for growth, product development, market </i></span><span style="font-family: arial, helvetica, sans-serif"><i>position, expected expenditures and financial results are forward-looking statements. Some of the forward-looking </i></span><span style="font-family: arial, helvetica, sans-serif"><i>statements may be identified by words like &quot;expects&quot;, &quot;anticipates&quot;, &quot;plans&quot;, &quot;intends&quot;, &quot;projects&quot;, &quot;indicates&quot;, and </i></span><span style="font-family: arial, helvetica, sans-serif"><i>similar expressions. These statements are not guarantees of future performance and involve a number of risks, </i></span><span style="font-family: arial, helvetica, sans-serif"><i>uncertainties and assumptions. Many factors, including those discussed more fully elsewhere in this release and in </i></span><span style="font-family: arial, helvetica, sans-serif"><i>documents which may be filed with the British Columbia Securities Commission, the Alberta Securities Commission, </i></span><span style="font-family: arial, helvetica, sans-serif"><i>the Ontario Securities Commission, the TSX Venture Exchange, as well as other USA Commissions, could cause </i></span><span style="font-family: arial, helvetica, sans-serif"><i>results to differ materially from those stated. These factors include, but are not limited to changes in the laws, </i></span><span style="font-family: arial, helvetica, sans-serif"><i>regulations, policies and economic conditions, including inflation, interest and foreign currency exchange rates, of </i></span><span style="font-family: arial, helvetica, sans-serif"><i>countries in which the Company does business; competitive pressures; successful integration of structural changes,</i></span><span style="font-family: arial, helvetica, sans-serif"><i>including restructuring plans, acquisitions, divestitures and alliances; cost of raw material, research and </i></span><span style="font-family: arial, helvetica, sans-serif"><i>development of new </i>products, including regulatory <i>approval and market acceptance; and seasonality of sales in </i></span><span style="font-family: arial, helvetica, sans-serif"><i>some products.</i></span></span></span></div>
<div><span style="font-size: 11px">&nbsp;</span></div>
<div><span style="font-size: 11px"><span style="font-size: 9px"><span style="font-family: arial, helvetica, sans-serif"><i>Neither the TSX Venture Exchange nor its Regulatory Service Provider (as that term is defined in the policies of the </i></span></span><span style="font-size: 9px"><span style="font-family: arial, helvetica, sans-serif"><i>TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.</i></span></span></span></div>
]]></content:encoded>
			<wfw:commentRss>http://www.pyng.com/in-focus/pyng-medical-announces-release-of-e-mat-%e2%80%93-emergency-medical-tourniquet-%e2%80%93-for-the-ems-market/?pi=194/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>MAT® Tourniquet has been adopted by the Indian Military</title>
		<link>http://www.pyng.com/in-focus/mat%c2%ae-tourniquet-has-been-adopted-by-the-indian-military/?pi=194</link>
		<comments>http://www.pyng.com/in-focus/mat%c2%ae-tourniquet-has-been-adopted-by-the-indian-military/?pi=194#comments</comments>
		<pubDate>Thu, 09 Jun 2011 21:36:07 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[In Focus]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[News Releases]]></category>

		<guid isPermaLink="false">http://www.pyng.com/?p=2729&amp;pi=194</guid>
		<description><![CDATA[Vancouver, British Columbia &#8211; June 9th, 2011 (PYT: TSX .V) Pyng Medical Corp. announced today that the Indian Militaryinitiated a standardization process with the MAT&#174; Tourniquet by purchasing 4,500 units in Pyng&#8217;s second quarter through its exclusive dealer in India, vTitan Corporation Private Limited.&#160; Pyng&#8217;s MAT&#174; Tourniquet has been widely accepted into various defense units [...]]]></description>
			<content:encoded><![CDATA[<p><strong><span style="font-size: 11px"><span style="font-family: arial, helvetica, sans-serif"><span id="more-2729"></span>Vancouver, British Columbia &ndash; June 9th, 2011</span></span></strong> <span style="font-size: 11px"><span style="font-family: arial, helvetica, sans-serif">(PYT: TSX .V) Pyng Medical Corp. announced today that the Indian Militaryinitiated a standardization process with the MAT&reg; Tourniquet by purchasing 4,500 units in Pyng&rsquo;s second quarter through its exclusive dealer in India, vTitan Corporation Private Limited.&nbsp; Pyng&rsquo;s MAT&reg; Tourniquet has been widely accepted into various defense units across India with the view to become &ldquo;standard of care&rdquo;, and will be adopted throughout the Indian military in the coming months.&nbsp; </p>
<p>	Bobby Shah, Chief Executive Officer for vTitan India commented; &ldquo;We are proud to represent a company that focuses on innovation.&rdquo;&nbsp; </p>
<p>	&ldquo;Due to the strong acceptance of the MAT&reg; Tourniquet, other Pyng products are now being considered by India Defense Units.&rdquo;&nbsp; Mr. Shah further added; &ldquo;We see Pyng product lines becoming a standard of care in the near future in India.&rdquo;<br />
	</span></span><br />
	<strong><span style="font-size: 11px"><span style="font-family: arial, helvetica, sans-serif">About MAT&reg; Tourniquet<br />
	</span></span></strong><span style="font-size: 11px"><span style="font-family: arial, helvetica, sans-serif">MAT&reg; Tourniquet provides fast and easy one-handed application and stops moderate to severe extremity blood loss to damaged and trapped limbs.&nbsp; It is the only tourniquet that meets all U.S. Department of Defense performance requirements (<a href="http://www.acep.org/workarea/downloadasset.aspx?id=40782">www.acep.org/workarea/downloadasset.aspx?id=40782</a>).&nbsp; The MAT&reg; is the silver award recipient for Design of the Decade from Industrial Designers Society of America</span></span>.</p>
<p>	<strong><span style="font-size: 11px"><span style="font-family: arial, helvetica, sans-serif">About Pyng Medical Corp. <br />
	</span></span></strong><span style="font-size: 11px"><span style="font-family: arial, helvetica, sans-serif">Pyng Medical Corp. commercializes award-winning trauma and resuscitation products for front-line critical care personnel. Pyng&rsquo;s expanded product portfolio includes a variety of innovative, lifesaving tools.&nbsp; With growing markets in North America, Europe and Asia, Pyng offers user-preferred medical devices for use by hospital staff, emergency medical services and military forces worldwide.</span></span></p>
<p><span style="font-size: 11px"><span style="font-family: arial, helvetica, sans-serif"><strong>For more information contact:<br />
	</strong>Nadine Gaston<br />
	VP of Global Sales and Marketing<br />
	Pyng Medical Corp. <br />
	206.226.3082<br />
	<a href="http://www.pyng.com">www.pyng.com</a></span></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt"><span style="font-family: arial, helvetica, sans-serif"><span style="font-size: 9px"><i><span lang="EN-US" style="color: black; mso-bidi-font-family: arial">Safe Harbour Statement; Forward-Looking Statements: This release may contain forward-looking statements based on management&#39;s expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company&#39;s strategy for growth, product development, market position, expected expenditures and financial results are forward-looking statements. Some of the forward-looking statements may be identified by words like &quot;expects&quot;, &quot;anticipates&quot;, &quot;plans&quot;, &quot;intends&quot;, &quot;projects&quot;, &quot;indicates&quot;, and similar expressions. These statements are not guarantees of future performance and involve a number of risks, uncertainties and assumptions. Many factors, including those discussed more fully elsewhere in this release and in documents which may be filed with the British Columbia Securities Commission, the Alberta Securities Commission, the Ontario Securities Commission, the TSX Venture Exchange, as well as other USA Commissions, could cause results to differ materially from those stated. These factors include, but are not limited to changes in the laws, regulations, policies and economic conditions, including inflation, interest and foreign currency exchange rates, of countries in which the Company does business; competitive pressures; successful integration of structural changes, including restructuring plans, acquisitions, divestitures and alliances; cost of raw material, research and development of new </span></i><span lang="EN-US" style="color: black; mso-bidi-font-family: arial; mso-bidi-font-style: italic">products, including regulatory <i>approval and market acceptance; and seasonality of sales in some products.</i></span></span></span><span lang="EN-US" style="font-family: 'verdana', 'sans-serif'; color: black; font-size: 8pt; mso-bidi-font-family: arial; mso-bidi-font-style: italic"><i><o:p></o:p></i></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt"><span style="font-family: arial, helvetica, sans-serif"><span style="font-size: 9px"><i><span lang="EN-US" style="color: black; mso-bidi-font-family: arial"><o:p>&nbsp;</o:p></span></i></span></span><span style="font-size: 9px"><i><span lang="EN-US" style="font-family: 'verdana', 'sans-serif'; color: black; mso-bidi-font-family: arial"><o:p></o:p></span></i></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt"><span style="font-family: arial, helvetica, sans-serif"><span style="font-size: 9px"><i style="mso-bidi-font-style: normal"><span lang="EN-US" style="color: black; mso-bidi-font-family: arial">Neither the TSX Venture Exchange nor its Regulatory Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.</span></i></span></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt"><span lang="EN-US" style="font-family: 'verdana', 'sans-serif'"><o:p></o:p></span></p>
]]></content:encoded>
			<wfw:commentRss>http://www.pyng.com/in-focus/mat%c2%ae-tourniquet-has-been-adopted-by-the-indian-military/?pi=194/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pyng Medical Corp. Reports Second Quarter Fiscal 2011 Results</title>
		<link>http://www.pyng.com/news/pyng-medical-corp-reports-second-quarter-fiscal-2011-results/?pi=194</link>
		<comments>http://www.pyng.com/news/pyng-medical-corp-reports-second-quarter-fiscal-2011-results/?pi=194#comments</comments>
		<pubDate>Tue, 24 May 2011 19:40:21 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[News Releases]]></category>

		<guid isPermaLink="false">http://www.pyng.com/?p=2563&amp;pi=194</guid>
		<description><![CDATA[Vancouver, B.C. Pyng Medical Corp. (PYT: TSX .V) today announced it&#8217;s financial and operating results for the three months ended March 31, 2011. All amounts are in Canadian dollars unless stated otherwise. &#160; The Company reported total sales of $1,289,270 for the three months ended March 31, 2011, down 18% compared with $1,578,715 for the [...]]]></description>
			<content:encoded><![CDATA[<p><span style="font-size: 11px"><b><span id="more-2563"></span>Vancouver, B.C. </b>Pyng Medical Corp. (PYT: TSX .V) today announced it&rsquo;s financial and operating </span><span style="font-size: 11px">results for the three months ended March 31, 2011. All amounts are in Canadian dollars unless stated </span><span style="font-size: 11px">otherwise.</span></p>
<div>&nbsp;</div>
<div><span style="font-size: 11px">The Company reported total sales of $1,289,270 for the three months ended March 31, 2011, down 18% </span><span style="font-size: 11px">compared with $1,578,715 for the same quarter last year, resulting from reduced orders from the U.S. </span><span style="font-size: 11px">military market due to the failure of the U.S. government to approve its budget. Gross margin for the </span><span style="font-size: 11px">quarter ended March 31, 2011 amounted to $809,803, a decrease of $265,762 from $1,075,565 reported a </span><span style="font-size: 11px">year ago. This was mainly due to the continuing appreciation of Canadian dollar against the U.S. dollar </span><span style="font-size: 11px">causing an unfavorable effect on the majority of sales dominated in U.S. dollars. Total operating expenses </span><span style="font-size: 11px">were $1,007,576, down to 78% of sales compared to $1,350,593 or 85% of sales for the same quarter last </span><span style="font-size: 11px">year.</span></div>
<div>&nbsp;</div>
<div><span style="font-size: 11px">The Company also reported a smaller net loss of $197,773 for this quarter, equal to a loss of $0.01 per </span><span style="font-size: 11px">share, compared to a net loss of $275,028 or $0.02 per share one year earlier. Earnings before interest, </span><span style="font-size: 11px">depreciation, amortization and taxes (&quot;EBITDA&quot;) from continuing operations were a loss of $63,558, </span><span style="font-size: 11px">which remained at the same level as last year of $64,615.</span></div>
<div>&nbsp;</div>
<div><span style="font-size: 11px">For the six months period, the total sales climbed 5% to $3,331,007 compared to $3,164,399 for the </span><span style="font-size: 11px">comparable period last year. Meanwhile, operating expenses were cut 19% to $1,998,571 from </span><span style="font-size: 11px">$2,452,784 incurred one year ago. The higher sales and reduction on operating expenses lead to a net </span><span style="font-size: 11px">income of $209,581 compared to a net loss of $244,311 reported last year.</span></div>
<div>&nbsp;</div>
<div><span style="font-size: 11px">As of March 31, 2011, the Company had a cash balance of $708,674 and working capital of $1,276,094, </span><span style="font-size: 11px">representing an increase of $425,681 and $514,839 respectively, compared to the amounts as at </span><span style="font-size: 11px">September 30, 2010. The overall financial position improved significantly with the increase in total assets </span><span style="font-size: 11px">by 2% to $8,233,910 and decrease in total liabilities by 22% to $2,289,242. Strong operating results in the </span><span style="font-size: 11px">first quarter and the private placement financing closed in December 2010 were primary contributors to </span><span style="font-size: 11px">improvements seen in cash and working capital.</span></div>
<div>&nbsp;</div>
<div><span style="font-size: 11px">Full audited financial results for fiscal year ended September 30, 2010 are available on SEDAR at </span><span style="font-size: 11px"><a href="www.sedar.com"><u><font color="#0000ff"><font color="#0000ff">www.sedar.com</font></font></u></a>.</span></div>
<div>&nbsp;</div>
<div><span style="font-size: 11px"><b>About Pyng Medical Corp.</b></span></div>
<div><span style="font-size: 11px">Pyng Medical Corp. commercializes award-winning trauma and resuscitation products for front-line </span><span style="font-size: 11px">critical care personnel. Pyng&rsquo;s expanded product portfolio includes a variety of innovative, lifesaving </span><span style="font-size: 11px">tools. With growing markets in North America, Europe and Asia, Pyng offers user-preferred medical </span><span style="font-size: 11px">devices for use by hospital staff, emergency medical services and military forces worldwide.</span></div>
<div><span style="font-size: 11px">&nbsp;</span></div>
<div><span style="font-size: 11px"><b>For More Information</b></span></div>
<div><span style="font-size: 11px">George Dorin</span></div>
<div><span style="font-size: 11px">Chief Financial Officer</span></div>
<div><span style="font-size: 11px">Pyng Medical Corp.</span></div>
<div><span style="font-size: 11px">(604) 303-7964 ext. 219</span></div>
<div><span style="font-size: 11px"><a href="www.pyng.com"><u><font color="#0000ff"><font color="#0000ff">www.pyng.com</font></font></u></a></span></div>
<div>&nbsp;</div>
<div><span style="font-size: 9px"><span style="font-family: arial, helvetica, sans-serif"><i>Safe Harbour Statement; Forward-Looking Statements: This release may contain forward-looking statements based </i></span><span style="font-family: arial, helvetica, sans-serif"><i>on management&#39;s expectations, estimates and projections. All statements that address expectations or projections </i></span><span style="font-family: arial, helvetica, sans-serif"><i>about the future, including statements about the Company&#39;s strategy for growth, product development, market </i></span><span style="font-family: arial, helvetica, sans-serif"><i>position, expected expenditures and financial results are forward-looking statements. Some of the forward-looking </i></span><span style="font-family: arial, helvetica, sans-serif"><i>statements may be identified by words like &quot;expects&quot;, &quot;anticipates&quot;, &quot;plans&quot;, &quot;intends&quot;, &quot;projects&quot;, &quot;indicates&quot;, and </i></span><span style="font-family: arial, helvetica, sans-serif"><i>similar expressions. These statements are not guarantees of future performance and involve a number of risks, </i></span><span style="font-family: arial, helvetica, sans-serif"><i>uncertainties and assumptions. Many factors, including those discussed more fully elsewhere in this release and in </i></span><span style="font-family: arial, helvetica, sans-serif"><i>documents which may be filed with the British Columbia Securities Commission, the Alberta Securities Commission, </i></span><span style="font-family: arial, helvetica, sans-serif"><i>the Ontario Securities Commission, the TSX Venture Exchange, as well as other USA Commissions, could cause </i></span><span style="font-family: arial, helvetica, sans-serif"><i>results to differ materially from those stated. These factors include, but are not limited to changes in the laws, </i></span><span style="font-family: arial, helvetica, sans-serif"><i>regulations, policies and economic conditions, including inflation, interest and foreign currency exchange rates, of </i></span><span style="font-family: arial, helvetica, sans-serif"><i>countries in which the Company does business; competitive pressures; successful integration of structural changes,</i></span><span style="font-family: arial, helvetica, sans-serif"><i>including restructuring plans, acquisitions, divestitures and alliances; cost of raw material, research and </i></span><span style="font-family: arial, helvetica, sans-serif"><i>development of new </i>products, including regulatory <i>approval and market acceptance; and seasonality of sales in </i></span><span style="font-family: arial, helvetica, sans-serif"><i>some products.</i></span></span></div>
<div>&nbsp;</div>
<div><span style="font-size: 9px"><span style="font-family: arial, helvetica, sans-serif"><i>Neither the TSX Venture Exchange nor its Regulatory Service Provider (as that term is defined in the policies of the </i></span></span><span style="font-size: 9px"><span style="font-family: arial, helvetica, sans-serif"><i>TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.</i></span></span></div>
]]></content:encoded>
			<wfw:commentRss>http://www.pyng.com/news/pyng-medical-corp-reports-second-quarter-fiscal-2011-results/?pi=194/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pyng Medical Corp. Reports First Quarter Fiscal 2011 Results</title>
		<link>http://www.pyng.com/news/pyng-medical-corp-reports-first-quarter-fiscal-2011-results/?pi=194</link>
		<comments>http://www.pyng.com/news/pyng-medical-corp-reports-first-quarter-fiscal-2011-results/?pi=194#comments</comments>
		<pubDate>Wed, 23 Feb 2011 20:26:20 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[News Releases]]></category>

		<guid isPermaLink="false">http://www.pyng.com/?p=2381&amp;pi=194</guid>
		<description><![CDATA[&#160;Vancouver, B.C. &#160;Pyng Medical Corp. (PYT: TSX .V) today announced it&#8217;s financial and operating results for the three months ended December 31, 2010.&#160;All amounts are in Canadian dollars unless stated otherwise. &#160; The Company continued revenue growth realized in the fourth quarter of last year and reported another record quarter with strong shipments of the [...]]]></description>
			<content:encoded><![CDATA[<div><span style="font-size: 11px"><span style="font-family: arial, helvetica, sans-serif"><strong><span id="more-2381"></span><span _fck_bookmark="1" style="display: none">&nbsp;</span>Vancouver, B.C. &nbsp;</strong>Pyng Medical Corp. (PYT: TSX .V) today announced it&rsquo;s financial and operating results for the three months ended December 31, 2010.&nbsp;All amounts are in Canadian dollars unless stated otherwise. </span></span></div>
<div><span style="font-size: 11px"><span style="font-family: arial, helvetica, sans-serif">&nbsp;</span></span></div>
<div><span style="font-size: 11px"><span style="font-family: arial, helvetica, sans-serif">The Company continued revenue growth realized in the fourth quarter of last year and reported another record quarter with strong shipments of the flagship product FAST1. Total sales of $2,041,737 were recorded for the first quarter of fiscal 2011, up 29% from $1,585,684 from the same quarter last year. Gross margin for the quarter ended December 31, 2010 amounted to $1,398,349, an increase of $265,443 from $1,132,906 reported a year ago. Gross margin as a percentage of sales decreased from 71% to 69%, which was mainly due to the continuing appreciation of Canadian dollar against the U.S. dollar (more than 93% of sales are in U.S. dollars). Total operating expenses were $990,995, down to 49% of sales compared to $1,102,189 or 69% of sales for the same quarter last year. This was primarily due to the lower labor costs, travel costs, and interest expenses incurred during the quarter.</span></span></div>
<div><span style="font-size: 11px"><span style="font-family: arial, helvetica, sans-serif">&nbsp;</span></span></div>
<div><span style="font-size: 11px"><span style="font-family: arial, helvetica, sans-serif">The Company also reported net income of $407,354 for this quarter, equal to earnings of $0.03 per share diluted, compared to $30,717 or $0.003 per share diluted for the same quarter of last year. Earnings before interest, depreciation, amortization and taxes (&ldquo;EBITDA&rdquo;) from continuing operations increased to $575,207, 27% of the sales, compared&nbsp;with the &nbsp;EBITDA of $151,835, or 10% of sales a year ago. </span></span></div>
<div><span style="font-size: 11px"><span style="font-family: arial, helvetica, sans-serif">&nbsp;</span></span></div>
<div><span style="font-size: 11px"><span style="font-family: arial, helvetica, sans-serif">As of December 31, 2010, the Company had a cash balance of $1,382,457 and working capital of $1,730,028, representing an increase of $1,099,464 and $968,773 respectively, compared to similar amounts as of September 30, 2010. Strong operating results and the private placement financing that closed in December 2010 were primary contributors to improvements seen in cash and working capital.</span></span></div>
<div><span style="font-size: 11px"><span style="font-family: arial, helvetica, sans-serif">&nbsp;&nbsp;</span></span></div>
<div><span style="font-size: 11px"><span style="font-family: arial, helvetica, sans-serif">Full audited financial results for fiscal year ended September 30, 2010 are available on SEDAR at <a href="http://www.sedar.com"><font color="#0000ff">www.sedar.com</font></a>.</span></span></div>
<div><span style="font-size: 11px"><span style="font-family: arial, helvetica, sans-serif">&nbsp;<b>&nbsp;</b></span></span></div>
<div><span style="font-size: 11px"><span style="font-family: arial, helvetica, sans-serif"><b>About Pyng Medical Corp.</b></span></span></div>
<div><span style="font-size: 11px"><span style="font-family: arial, helvetica, sans-serif"><span style="line-height: 115%; color: black">Pyng Medical Corp. commercializes award-winning trauma and resuscitation products for front-line critical care personnel. Pyng&rsquo;s expanded product portfolio includes a variety of innovative, lifesaving tools.&nbsp; With growing markets in North America, Europe and Asia, Pyng offers user-preferred medical devices for use by hospital staff, emergency medical services and military forces worldwide.&nbsp;</span></span></span></div>
<div><span style="font-size: 11px"><span style="font-family: arial, helvetica, sans-serif"><strong>&nbsp;</strong></span></span></div>
<div><span style="font-size: 11px"><span style="font-family: arial, helvetica, sans-serif"><strong>For More Information&nbsp;</strong></span></span></div>
<div>
<p><span style="font-size: 11px"><span style="font-family: arial, helvetica, sans-serif"><strong><span style="font-weight: normal">George Dorin<br />
		</span></strong></span></span><span style="font-size: 10px"><strong><span style="font-weight: normal"><strong><span style="font-weight: normal">Chief Financial Officer<u> <br />
		</u>Pyng Medical Corp.<br />
		(604) 303-7964 ext. 219<br />
		</span></strong></span></strong></span></p>
<div>&nbsp;</div>
<div><span style="font-size: 9px"><i><span style="color: black">Safe</span></i><i><span style="color: black"> Harbour</span></i><i><span style="color: black"> Statement; Forward-Looking Statements: This release may contain forward-looking statements based on management&#39;s expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company&#39;s strategy for growth, product development, market position, expected expenditures and financial results are forward-looking statements. Some of the forward-looking statements may be identified by words like &quot;expects&quot;, &quot;anticipates&quot;, &quot;plans&quot;, &quot;intends&quot;, &quot;projects&quot;, &quot;indicates&quot;, and similar expressions. These statements are not guarantees of future performance and involve a number of risks, uncertainties and assumptions. Many factors, including those discussed more fully elsewhere in this release and in documents which may be filed with the British Columbia Securities Commission, the Alberta Securities Commission, the Ontario Securities Commission, the TSX Venture Exchange, as well as other USA Commissions, could cause results to differ materially from those stated. These factors include, but are not limited to changes in the laws, regulations, policies and economic conditions, including inflation, interest and foreign currency exchange rates, of countries in which the Company does business; competitive pressures; successful integration of structural changes, including restructuring plans, acquisitions, divestitures and alliances; cost of raw material, research and development of new </span></i><span style="color: black">products, including regulatory <i>approval and market acceptance; and seasonality of sales in some products.</i></span></span></div>
<div><span style="font-size: 9px">&nbsp;</span></div>
<div><span style="font-size: 9px"><i><span style="color: black">Neither the TSX Venture Exchange nor its Regulatory Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.</span></i></span></div>
<p><span _fck_bookmark="1" style="display: none">&nbsp;</span></p>
</div>
]]></content:encoded>
			<wfw:commentRss>http://www.pyng.com/news/pyng-medical-corp-reports-first-quarter-fiscal-2011-results/?pi=194/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pyng Medical Provides Update on FASTx®</title>
		<link>http://www.pyng.com/in-focus/pyng-medical-provides-update-on-fastx%c2%ae/?pi=194</link>
		<comments>http://www.pyng.com/in-focus/pyng-medical-provides-update-on-fastx%c2%ae/?pi=194#comments</comments>
		<pubDate>Thu, 10 Feb 2011 20:56:01 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[In Focus]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[News Releases]]></category>

		<guid isPermaLink="false">http://www.pyng.com/?p=2353&amp;pi=194</guid>
		<description><![CDATA[&#160;Vancouver, British Columbia &#8211; February 10th 2011 (PYT: TSX .V) Pyng Medical announced that it has completed a root-cause analysis on FASTx&#174; in follow-up to reported insertion failures in a handful of early military training environments.&#160;From this analysis Pyng has validated that there are times where lateral motion can bend the insertion needle (stylet).&#160;This has [...]]]></description>
			<content:encoded><![CDATA[<div><span id="more-2353"></span><span style="font-size: 11px"><span style="font-family: arial, helvetica, sans-serif"><b><span style="color: black"><span _fck_bookmark="1" style="display: none">&nbsp;</span>Vancouver, British Columbia &ndash; February 10<sup>th</sup> 2011</span></b><span style="color: black"> (PYT: TSX .V) Pyng Medical announced that it has completed a root-cause analysis on FASTx</span><span style="color: black">&reg; </span>in follow-up to reported insertion failures in a handful of early military training environments.&nbsp;From this analysis Pyng has validated that there are times where lateral motion can bend the insertion needle (stylet).&nbsp;This has not been observed in the unconscious patient or in cadaver validation; however it has been seen with live/conscious healthy patients in training settings. Pyng is now pursuing several options to mitigate root-cause and anticipates choosing a final solution within the next several months. </span></span></div>
<div><span style="font-size: 11px"><span style="font-family: arial, helvetica, sans-serif">&nbsp;</span></span></div>
<div><span style="font-size: 11px"><span style="font-family: arial, helvetica, sans-serif">Mark Hodge, President and Chief Executive Officer for Pyng, commented; &quot;Shortening the FASTx&reg; redevelopment timeline, while at the same time bringing back an even more robust product to market, is Pyng Medical&#39;s number one priority. The company is by no means &quot;accepting a long timeline&quot; and will engage all necessary resources to minimize the duration of the process.&rdquo;</span></span></div>
<div><span style="font-size: 11px"><span style="font-family: arial, helvetica, sans-serif">&nbsp;</span></span></div>
<div><span style="font-size: 11px"><span style="font-family: arial, helvetica, sans-serif">&nbsp;</span></span></div>
<div><span style="font-size: 11px"><span style="font-family: arial, helvetica, sans-serif"><strong><span style="line-height: 115%">About Pyng Medical Corp.&nbsp;<br />
	</span></strong></span><span style="line-height: 115%; color: black">Pyng Medical Corp. commercializes award-winning trauma and resuscitation products for front-line critical care personnel. Pyng&rsquo;s expanded product portfolio includes a variety of innovative, lifesaving tools.&nbsp; With growing markets in North America, Europe and Asia, Pyng offers user-preferred medical devices for use by hospital staff, emergency medical services and military forces worldwide.&nbsp;</span></span></div>
<div><span style="font-size: 11px"><span style="font-family: arial, helvetica, sans-serif"><b>&nbsp;</b></span></span></div>
<div><strong><span style="font-size: 11px"><span style="font-family: arial, helvetica, sans-serif"><span style="line-height: 115%">For more information contact:</span></span></span></strong></div>
<div><span style="font-size: 11px"><span style="font-family: arial, helvetica, sans-serif"><span style="line-height: 115%">Pyng Medical Corp.</span></span></span></div>
<div><span style="font-size: 11px"><span style="font-family: arial, helvetica, sans-serif"><span style="line-height: 115%">Mark F. Hodge</span></span></span></div>
<div><span style="font-size: 11px"><span style="font-family: arial, helvetica, sans-serif"><span style="line-height: 115%">Chief Executive Officer</span></span></span></div>
<div><span style="font-size: 11px"><span style="font-family: arial, helvetica, sans-serif"><span style="line-height: 115%">1-800-349-7964 (x208)</span></span></span></div>
<div style="line-height: 115%">&nbsp;</div>
<div>&nbsp;</div>
<div>&nbsp;</div>
<div><span style="font-size: 9px"><span style="font-family: arial, helvetica, sans-serif"><i><span style="color: black">Safe Harbour Statement; Forward-Looking Statements: This release may contain forward-looking statements based on management&#39;s expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company&#39;s strategy for growth, product development, market position, expected expenditures and financial results are forward-looking statements. Some of the forward-looking statements may be identified by words like &quot;expects&quot;, &quot;anticipates&quot;, &quot;plans&quot;, &quot;intends&quot;, &quot;projects&quot;, &quot;indicates&quot;, and similar expressions. These statements are not guarantees of future performance and involve a number of risks, uncertainties and assumptions. Many factors, including those discussed more fully elsewhere in this release and in documents which may be filed with the British Columbia Securities Commission, the Alberta Securities Commission, the Ontario Securities Commission, the TSX Venture Exchange, as well as other USA Commissions, could cause results to differ materially from those stated. These factors include, but are not limited to changes in the laws, regulations, policies and economic conditions, including inflation, interest and foreign currency exchange rates, of countries in which the Company does business; competitive pressures; successful integration of structural changes, including restructuring plans, acquisitions, divestitures and alliances; cost of raw material, research and development of new </span></i><span style="color: black">products, including regulatory <i>approval and market acceptance; and seasonality of sales in some products.</i></span></span></span></div>
<div><span style="font-size: 9px"><span style="font-family: arial, helvetica, sans-serif">&nbsp;</span></span></div>
<div><span style="font-size: 9px"><span style="font-family: arial, helvetica, sans-serif"><i><span style="color: black">Neither the TSX Venture Exchange nor its Regulatory Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.</span></i></span></span></div>
]]></content:encoded>
			<wfw:commentRss>http://www.pyng.com/in-focus/pyng-medical-provides-update-on-fastx%c2%ae/?pi=194/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

